Skip to main content

Physician Search

 


Displaying 1 - 1 of 1

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Kidney (Renal Cell)

This study will be comparing tivozanib in combination with nivolumab to tivozanib alone in subjects with advanced Renal Cell Carcinoma (RCC) who have had 1 or 2 prior lines of therapy, one of which was an Immune Checkpoint Inhibitor (ICI).
Kidney (Renal Cell)
III
Beckermann, Kathryn
NCT04987203
VICCURO2178